Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 7Unknown 6Terminated 2Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Breast Neoplasms 723Neoplasms 461Prostatic Neoplasms 398Carcinoma, Non-Small-Cell Lung 388Lung Neoplasms 311Leukemia, Myeloid, Acute 301Multiple Myeloma 270Colorectal Neoplasms 243Neoplasm Metastasis 240Pancreatic Neoplasms 238Leukemia 235Melanoma 217Lymphoma 213Precursor Cell Lymphoblastic Leukemia-Lymphoma 204Brain Neoplasms 195Recurrence 178Head and Neck Neoplasms 177Lymphoma, Non-Hodgkin 174Myelodysplastic Syndromes 168Leukemia, Lymphocytic, Chronic, B-Cell 168Ovarian Neoplasms 160Carcinoma, Hepatocellular 154Glioblastoma 149Carcinoma, Renal Cell 137Rectal Neoplasms 134Colonic Neoplasms 129Lymphoma, Large B-Cell, Diffuse 125Lymphoma, Follicular 125Hodgkin Disease 116Squamous Cell Carcinoma of Head and Neck 109

Interventions

lanreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER × Acromegaly × Clear all
NCT02419664 2022-03-31

Ga-68-DOTATOC -PET in the Management of Pituitary Tumours

Göteborg University

Phase 3 Terminated
22 enrolled
Endocrine

Acromegaly, Pituitary Diseases, Pituitary Neoplasms

NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Saint John's Cancer Institute

Phase 4 Terminated
4 enrolled 5 charts
Endocrine

Acromegaly, Gigantism, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡